Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Exon: Number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = exons 3 to 7, 8i_9 = border intron 8/exon 9.
DNA change (cDNA): Description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup.
RNA change: Description of variant at RNA level (following HGVS recommendations).
- r.123c>u
- r.? = unknown
- r.(?) = RNA not analysed but probably transcribed copy of DNA variant
- r.spl? = RNA not analysed but variant probably affects splicing
- r.(spl?) = RNA not analysed but variant may affect splicing
- r.0? = change expected to abolish transcription
Protein: Description of variant at protein level (following HGVS recommendations).
- p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
- p.Arg345Pro = change derived from RNA analysis
- p.? = unknown effect
- p.0? = probably no protein produced
Allele: On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.
Type: Type of variant at DNA level; note that the variant type can also be derived from the variant description (for all levels).
All options:
- Substitution
- Deletion
- Duplication
- Insertion
- Inversion
- Insertion/Deletion
- Translocation
- Other/Complex
DNA change (genomic) (hg19): Description of variant at DNA level, based on the genomic DNA reference sequence (following HGVS recommendations).
- g.12345678C>T
- g.12345678_12345890del
- g.12345678_12345890dup
Reference: Reference to publication describing the variant, including links to OMIM (when available), PubMed or or other source, e.g. "den Dunnen ASHG2003 P2346".
DB-ID: Database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro.
Frequency: Frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested).
Variant remarks: Remarks regarding the variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
ClassClinical: ClassClinical
Template: Template(s) used to detect the sequence variant; DNA = genomic DNA, RNA = RNA (cDNA).
All options:
- DNA
- RNA = RNA (cDNA)
- Protein
- ? = unknown
Technique: Technique(s) used to identify the sequence variant.
All options:
- ? = Unknown
- arrayCGH = array for Comparative Genomic Hybridisation
- arraySEQ = array for resequencing
- arraySNP = array for SNP typing
- arrayCNV = array for Copy Number Variation (SNP and CNV probes)
- BESS = Base Excision Sequence Scanning
- CMC = Chemical Mismatch Cleavage
- CSCE = Conformation Sensitive Capillary Electrophoresis
- DGGE = Denaturing-Gradient Gel-Electrophoresis
- DHPLC = Denaturing High-Performance Liquid Chromatography
- DOVAM = Detection Of Virtually All Mutations (SSCA variant)
- ddF = dideoxy Fingerprinting
- DSCA = Double-Strand DNA Conformation Analysis
- EMC = Enzymatic Mismatch Cleavage
- HD = HeteroDuplex analysis
- MCA = high-resolution Melting Curve Analysis (hrMCA)
- IHC = Immuno-Histo-Chemistry
- MAPH = Multiplex Amplifiable Probe Hybridisation
- MLPA = Multiplex Ligation-dependent Probe Amplification
- SEQ-NG = Next-Generation Sequencing
- SEQ-NG-H = Next-Generation Sequencing - Helicos
- SEQ-NG-I = Next-Generation Sequencing - Illumina/Solexa
- SEQ-NG-R = Next-Generation Sequencing - Roche/454
- SEQ-NG-S = Next-Generation Sequencing - SOLiD
- Northern = Northern blotting
- PCR = Polymerase Chain Reaction
- PCRdig = PCR + restriction enzyme digestion
- PCRlr = PCR, long-range
- PCRm = PCR, multiplex
- PCRq = PCR, quantitative
- PAGE = Poly-Acrylamide Gel-Electrophoresis
- PTT = Protein Truncation Test
- PFGE = Pulsed-Field Gel-Electrophoresis (+Southern)
- RT-PCR = Reverse Transcription and PCR
- SEQ = SEQuencing
- SBE = Single Base Extension
- SSCA = Single-Strand DNA Conformation polymorphism Analysis (SSCP)
- SSCAf = SSCA, fluorescent (SSCP)
- Southern = Southern blotting
- TaqMan = TaqMan assay
- Western = Western Blotting
Reference: Reference to publication describing the individual/family, possibly giving more phenotypic details than listed in this database entry, including link to PubMed or other source, e.g. "den Dunnen ASHG2003 P2346". References in the "Country:City" format indicate that the variant was submitted directly to this database by the laboratory indicated.
Remarks: Remarks about the individual.
Gender: Gender
Age: Age
α-thal genotype: α-thal genotype
β-thal genotype: β-thal genotype
How to query this table
All list views have search fields which can be used to search data.
You can search for a complete word or you can search for a part of a search term.
If you enclose two or more words in double quotes, LOVD will search for the combination of those words only exactly in the order you specify.
Note that search terms are case-insensitive and that wildcards such as * are treated as normal text!
For all options, like "and", "or", and "not" searches, or searching for prefixes or suffixes, see the table below.
Operator |
Column type |
Example |
Matches |
|
Text |
Arg |
all entries containing 'Arg' |
space |
Text |
Arg Ser |
all entries containing 'Arg' and 'Ser' |
| |
Text |
Arg|Ser |
all entries containing 'Arg' or 'Ser' |
! |
Text |
!fs |
all entries not containing 'fs' |
^ |
Text |
^p.(Arg |
all entries beginning with 'p.(Arg' |
$ |
Text |
Ser)$ |
all entries ending with 'Ser)' |
="" |
Text |
="" |
all entries with this field empty |
="" |
Text |
="p.0" |
all entries exactly matching 'p.0' |
!="" |
Text |
!="" |
all entries with this field not empty |
!="" |
Text |
!="p.0" |
all entries not exactly matching 'p.0?' |
combination |
Text |
*|Ter !fs |
all entries containing '*' or 'Ter' but not containing 'fs' |
|
Date |
2020 |
all entries matching the year 2020 |
| |
Date |
2020-03|2020-04 |
all entries matching March or April, 2020 |
! |
Date |
!2020-03 |
all entries not matching March, 2020 |
< |
Date |
<2020 |
all entries before the year 2020 |
<= |
Date |
<=2020-06 |
all entries in or before June, 2020 |
> |
Date |
>2020-06 |
all entries after June, 2020 |
>= |
Date |
>=2020-06-15 |
all entries on or after June 15th, 2020 |
combination |
Date |
2019|2020 <2020-03 |
all entries in 2019 or 2020, and before March, 2020 |
|
Numeric |
23 |
all entries exactly matching 23 |
| |
Numeric |
23|24 |
all entries exactly matching 23 or 24 |
! |
Numeric |
!23 |
all entries not exactly matching 23 |
< |
Numeric |
<23 |
all entries lower than 23 |
<= |
Numeric |
<=23 |
all entries lower than, or equal to, 23 |
> |
Numeric |
>23 |
all entries higher than 23 |
>= |
Numeric |
>=23 |
all entries higher than, or equal to, 23 |
combination |
Numeric |
>=20 <30 !23 |
all entries with values from 20 to 29, but not equal to 23 |
Some more advanced examples:
Example |
Matches |
Asian |
all entries containing 'Asian', 'asian', including 'Caucasian', 'caucasian', etc. |
Asian !Caucasian |
all entries containing 'Asian' but not containing 'Caucasian' |
Asian|African !Caucasian |
all entries containing 'Asian' or 'African', but not containing 'Caucasian' |
"South Asian" |
all entries containing 'South Asian', but not containing 'South East Asian' |
To sort on a certain column, click on the column header or on the arrows.
If that column is already selected to sort on, the sort order will be swapped.
The column currently sorted on has a darker blue background color than the other columns.
The up and down arrows next to the column name indicate the current sorting direction.
When sorting on any field other than the default, LOVD will sort secondarily on the default sort column.
|
Legend |
How to query |
« First |
Prev |
|
1 |
2 |
3 |
4 |
5 |
|
Next |
Last » |

 Effect
|

 Exon
|

 DNA change (cDNA)
|

 RNA change
|

 Protein
|

 Allele
|

 Type
|

 DNA change (genomic) (hg19)
|

 Reference
|

 DB-ID
|

 Frequency
|
 Variant remarks
|

 ClassClinical
|

 Template
|

 Technique
|

 Disease
|

 Reference
|
 Remarks
|

 Gender
|

 Age
|

 α-thal genotype
|

 β-thal genotype
|

 Panel size
|

 Owner
|
./. |
01 |
c.-3_12del15 |
- |
p.? |
Unknown |
Deletion |
- |
GenBank |
LMNA_00101 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
08 |
c.1458G>T/C |
- |
p.Lys486Asn |
Unknown |
Substitution |
- |
GenBank |
LMNA_00250 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
10 |
c.1609 |
- |
- |
Unknown |
Substitution |
- |
GenBank |
LMNA_00183 |
- |
This new heart |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
11 |
c.1761G>? |
- |
p.Leu587Leu |
Unknown |
Substitution |
- |
GenBank |
LMNA_00244 |
- |
LMNA genetic variant identified by HRM analysis |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
11 |
c.1824C>? |
- |
p.Gly608Gly |
Unknown |
Substitution |
- |
GenBank |
LMNA_00098 |
- |
The study of nuclear envelope functions is providing
remarkable new insights into fundamental aspects of
nuclear structure and dynamics.
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.357C>? |
- |
p.Arg119Arg |
Unknown |
Substitution |
- |
GenBank |
LMNA_00161 |
- |
genetic variant identified by HRM analysis |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
03 |
c.585C>G/A |
- |
p.Asn195Lys |
Unknown |
Substitution |
- |
GenBank |
LMNA_00255 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
04 |
c.780G>C/T |
- |
p.Lys260Asn |
Unknown |
Substitution |
- |
GenBank |
LMNA_00257 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
05 |
c.861T>? |
- |
p.Ala287Ala |
Unknown |
Substitution |
- |
GenBank |
LMNA_00243 |
- |
LMNA genetic variant identified by HRM analysis |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.? |
- |
p.? |
Unknown |
Deletion |
- |
GenBank |
LMNA_00225 |
- |
This novel LMNA deletion causes a distinct, highly malignant cardiomyopathy with early-onset primary cardiac
fibrosis likely due to an effect of the shortened mutant protein, which secondarily leads to arrhythmias and
end-stage cardiac failure |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
00 |
c.? |
- |
p.? |
Unknown |
Substitution |
- |
GenBank |
LMNA_00087 |
- |
The
presence of short inverted sequence homologies at the breakpoint junctions suggested a mutational event involving serial
replication slippage in trans during DNA replication. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.11C>G |
- |
p.Pro4Arg |
Unknown |
Substitution |
- |
GenBank |
LMNA_00187 |
- |
APS patients have a few overlapping but some distinct clinical features as comparedrnwith HGPS and mandibuloacral dysplasia. The pathogenesis of clinical manifestations in APS pa-rntients seems not to be related to accumulation of mutant farnesylated prelamin A. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.16C>T |
- |
p.Gln6X |
Unknown |
Substitution |
- |
GenBank |
LMNA_00004 |
- |
This transition predicts a
truncated lamin A/C composed of only the five amino-terminal
amino acids. The mutation creates a new BfaI site, which was
used to screen all family members. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.16C>T |
- |
p.Gln6fsX |
Unknown |
Substitution |
- |
GenBank |
LMNA_00004 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.28_29insA |
- |
p.Thr10AsnfsX31 |
Unknown |
Insertion |
- |
GenBank |
LMNA_00053 |
- |
This is a previously described (R377H) mutation in another family with a quadriceps myopathy associated with DCM. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.29C>T |
- |
p.Thr10Ile |
Unknown |
Substitution |
- |
GenBank |
LMNA_00113 |
- |
These patients extend the spectrum of abnormal
phenotypes caused by LMNA mutations, which may
complicate the clinical diagnosis of some patients with
laminopathies, but suggest that LMNA is a good
candidate for evaluation in patients with other atypical
progeria phenotypes |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.29C>T |
- |
p.Thr10Ile |
Unknown |
Substitution |
- |
GenBank |
LMNA_00113 |
- |
APS patients have a few overlapping but some distinct clinical features as compared
with HGPS and mandibuloacral dysplasia. The pathogenesis of clinical manifestations in APS pa-
tients seems not to be related to accumulation of mutant farnesylated prelamin A. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.29C>T |
- |
p.Thr10Ile |
Unknown |
Substitution |
- |
GenBank |
LMNA_00113 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.31del |
- |
p.Arg11AlafsX85 |
Unknown |
Deletion |
- |
GenBank |
LMNA_00197 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.31delC |
- |
p.Arg11AlafsX85 |
Unknown |
Deletion |
- |
GenBank |
LMNA_00051 |
- |
The mutation leads to frame shift change. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.51C>T |
- |
p.Ser17Ser |
Unknown |
Substitution |
- |
GenBank |
LMNA_00242 |
- |
genetic variant identified by HRM analysis |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.73C>G |
- |
p.Arg25Gly |
Unknown |
Substitution |
- |
GenBank |
LMNA_00101 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.73C>G |
- |
p.Arg25Gly |
Unknown |
Substitution |
- |
GenBank |
LMNA_00101 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.73C>G |
- |
p.Arg25Gly |
Unknown |
Substitution |
- |
GenBank |
LMNA_00101 |
- |
The mutation R25G in exon 1 of LMNA gene we reported here in a Chinese family had a phenotype of
malignant arrhythmia and mild LGMD, suggesting that patients with familial DCM, conduction system defects and skeletal
muscle dystrophy should be screened by genetic testing for the LMNA gene |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.73C>T |
- |
p.Arg25Cys |
Unknown |
Substitution |
- |
GenBank |
LMNA_00122 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.74G>C |
- |
p.Arg25Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00012 |
- |
The presence of this mutation removes a SfaNI recognition site from the exon 1 amplication product. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.82C>T |
- |
p.Arg28Trp |
Unknown |
Substitution |
- |
GenBank |
LMNA_00078 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.82C>T |
- |
p.Arg28Trp |
Unknown |
Substitution |
- |
GenBank |
LMNA_00078 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.82C>T |
- |
p.Arg28Trp |
Unknown |
Substitution |
- |
GenBank |
LMNA_00078 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.82C>T |
- |
p.Arg28Trp |
Unknown |
Substitution |
- |
GenBank |
LMNA_00078 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.94_96delAAG |
- |
p.Lys32del |
Unknown |
Deletion |
- |
GenBank |
LMNA_00088 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.94_96delAAG |
- |
p.Lys32del |
Unknown |
Deletion |
- |
GenBank |
LMNA_00088 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.98A>G |
- |
p.Glu33Gly |
Unknown |
Substitution |
- |
GenBank |
LMNA_00109 |
- |
To our knowledge, this is the first LMNA mutation to bernfound in an autosomal dominant form of CMT2, andrnimplies that LMNA is responsible for both autosomalrndominant and recessive forms of axonal Charcot-rnMarie-Tooth disease. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.103C>G |
- |
p.Leu35Val |
Unknown |
Substitution |
- |
GenBank |
LMNA_00102 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.103C>G |
- |
p.Leu35Val |
Unknown |
Substitution |
- |
GenBank |
LMNA_00102 |
- |
The fact that the p.L35P change leads to an
L-CMD phenotype, whereas the p.L35V mutation
leads to an EDMD phenotype, further demonstrates
the challenge in predicting phenotype/
genotype correlations in laminopathies |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.104T>C |
- |
p.Leu35Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00221 |
- |
The fact that the p.L35P change leads to an
L-CMD phenotype, whereas the p.L35V mutation
leads to an EDMD phenotype, further demonstrates
the challenge in predicting phenotype/
genotype correlations in laminopathies |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.115A>T |
- |
p.Asn39Tyr |
Unknown |
Substitution |
- |
GenBank |
LMNA_00204 |
- |
it had notrnbeen identified previously, (ii) it was absent in more thanrn1000 normal chromosomes, and (iii) it concerns a highlyrnconserved nucleotide and amino acid within the LMNArngene and the lamin A/C protein. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.127G>A |
- |
p.Ala43Thr |
Unknown |
Substitution |
- |
GenBank |
LMNA_00019 |
- |
lamin A/C proteins with alteration at positions 43 may be defective in protein oligomerization. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.134A>G |
- |
p.Tyr45Cys |
Unknown |
Substitution |
- |
GenBank |
LMNA_00061 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.139G>C |
- |
p.Asp47His |
Unknown |
Substitution |
- |
GenBank |
LMNA_00129 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.139G>T |
- |
p.Asp47Tyr |
Unknown |
Substitution |
- |
GenBank |
LMNA_00190 |
- |
patient with the LMNA D47Y mutation exhibited clinical signs of premature ageing |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.148C>A |
- |
p.Arg50Ser |
Unknown |
Substitution |
- |
GenBank |
LMNA_00013 |
- |
The C148A mutation creates an additional AluI restriction endonuclease site within the exon 1 amplimer, allowing the rapid detection of this mutation in his daughter, who presented at age 24 with isolated quadricep weakness, and at age 28 with atrial and ventricular extrasystoles with no AV block. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.148C>A |
- |
p.Arg50Ser |
Unknown |
Substitution |
- |
GenBank |
LMNA_00013 |
- |
The study of nuclear envelope functions is providing
remarkable new insights into fundamental aspects of
nuclear structure and dynamics.
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.148C>A |
- |
p.Arg50Ser |
Unknown |
Substitution |
- |
GenBank |
LMNA_00013 |
- |
The first report to suggest that the A-type lamin mutations may be differentially dysfunctional for the same LMNA mutation. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.149G>C |
- |
p.Arg50Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00062 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.155T>C |
- |
p.Leu52Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00136 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.157G>A |
- |
p.Glu53Val |
Unknown |
Substitution |
- |
GenBank |
LMNA_00102 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.178C>G |
- |
p.Arg60Gly |
Unknown |
Substitution |
- |
GenBank |
LMNA_00009 |
- |
Mutation Arg60Gly creates Sau 96I restriction enzyme site. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.178C>G |
- |
p.Arg60Gly |
Unknown |
Substitution |
- |
GenBank |
LMNA_00009 |
- |
It does not led to an increased loss of emerin from the nuclear envelope, compared to wild-type. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.178C>G |
- |
p.Arg60Gly |
Unknown |
Substitution |
- |
GenBank |
LMNA_00009 |
- |
The findings demonstrate that the exon 1 c.178 C/G, p.Arg 60 Gly LMNA
gene mutation is associated with a novel phenotype featuring cardiac
involvement followed by late lipodystrophy, diabetes, and peripheral axonal
neuropathy. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.178C>G |
- |
p.Arg60Gly |
Unknown |
Substitution |
- |
GenBank |
LMNA_00009 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.184C>G |
- |
p.Arg62Gly |
Unknown |
Substitution |
- |
GenBank |
LMNA_00079 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.184C>G |
- |
p.Arg62Gly |
Unknown |
Substitution |
- |
GenBank |
LMNA_00079 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.188T>A |
- |
p.Ile63Asn |
Unknown |
Substitution |
- |
GenBank |
LMNA_00076 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.188T>A |
- |
p.Ile63Asn |
Unknown |
Substitution |
- |
GenBank |
LMNA_00076 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.188T>G |
- |
p.Ile63Ser |
Unknown |
Substitution |
- |
GenBank |
LMNA_00063 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.188T>G |
- |
p.Ile63Ser |
Unknown |
Substitution |
- |
GenBank |
LMNA_00063 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.202_207del |
- |
p.Glu68_Val69del |
Unknown |
Deletion |
- |
GenBank |
LMNA_00247 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.244G>A |
- |
p.Glu82Lys |
Unknown |
Substitution |
- |
GenBank |
LMNA_00099 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.244G>A |
- |
p.Glu82Lys |
Unknown |
Substitution |
- |
GenBank |
LMNA_00099 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.244G>A |
- |
p.Glu82Lys |
Unknown |
Substitution |
- |
GenBank |
LMNA_00099 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.254T>G |
- |
p.Leu85Arg |
Unknown |
Substitution |
- |
GenBank |
LMNA_00008 |
- |
The Leu85Arg mutation (in Family C) abolishes a Sac I restriction-enzyme site. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.254T>G |
- |
p.Leu85Arg |
Unknown |
Substitution |
- |
GenBank |
LMNA_00008 |
- |
Of the four lamin A mutants that we have examined,only lamin A L85R (LaA L85R) showed any obvious preponderance of lamin A0 over mature lamin A (1.6-fold relative to wild-type). |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.254T>G |
- |
p.Leu85Arg |
Unknown |
Substitution |
- |
GenBank |
LMNA_00008 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.266G>T |
- |
p.Arg89Leu |
Unknown |
Substitution |
- |
GenBank |
LMNA_00030 |
- |
The subsititution leads to Arg89Leu. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.266G>T |
- |
p.Arg89Leu |
Unknown |
Substitution |
- |
GenBank |
LMNA_00030 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.266G>T |
- |
p.Arg89Leu |
Unknown |
Substitution |
- |
GenBank |
LMNA_00030 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.266G>T |
- |
p.Arg89Leu |
Unknown |
Substitution |
- |
GenBank |
LMNA_00030 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.274C>T |
- |
p.Leu92Phe |
Unknown |
Substitution |
- |
GenBank |
LMNA_00191 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.274C>T |
- |
p.Leu92Phe |
Unknown |
Substitution |
- |
GenBank |
LMNA_00191 |
- |
They exhibited prelamin A accumulation, increased oxidative stress, decreased expression of
mitochondrial respiratory chain proteins and premature cellular senescence |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.274C>T |
- |
p.Leu92Phe |
Unknown |
Substitution |
- |
GenBank |
LMNA_00191 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.289A>G |
- |
p.Lys97Glu |
Unknown |
Substitution |
- |
GenBank |
LMNA_00025 |
- |
The presence of the mutation can be seen in the normal person of the patients' family. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.289A>G |
- |
p.Lys97Glu |
Unknown |
Substitution |
- |
GenBank |
LMNA_00025 |
- |
The mutation transforms Lys to Glu. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.289A>G |
- |
p.Lys97Glu |
Unknown |
Substitution |
- |
GenBank |
LMNA_00025 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.302G>C |
- |
p.Arg101Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00190 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.302G>C |
- |
p.Arg101Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00190 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.302G>C |
- |
p.Arg101Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00190 |
- |
This is the first report of limb girdle muscular dystrophy with cardiac disorders shown to harbor a mutation of the lamin A/C gene in a Taiwanese family. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.305T>C |
- |
p.Leu102Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00142 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.331G>A |
- |
p.Glu111Lys |
Unknown |
Substitution |
- |
GenBank |
LMNA_00109 |
- |
APS patients have a few overlapping but some distinct clinical features as compared
with HGPS and mandibuloacral dysplasia. The pathogenesis of clinical manifestations in APS pa-
tients seems not to be related to accumulation of mutant farnesylated prelamin A. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.331G>T |
- |
p.Glu111X |
Unknown |
Substitution |
- |
GenBank |
LMNA_00024 |
- |
The presence of the mutation can be seen in the normal person of the patients' family. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.331G>T |
- |
p.Glu111fsX |
Unknown |
Substitution |
- |
GenBank |
LMNA_00024 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.334_336delGAG |
- |
p.Glu112del |
Unknown |
Deletion |
- |
GenBank |
LMNA_00064 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
01 |
c.334_336delGAG |
- |
p.Glu112del |
Unknown |
Deletion |
- |
GenBank |
LMNA_00064 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.357-20C>T |
- |
- |
Unknown |
Substitution |
- |
GenBank |
LMNA_00160 |
- |
genetic variant identified by HRM analysis |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.357-1G>A |
- |
- |
Unknown |
Substitution |
- |
GenBank |
LMNA_00205 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.357-1G>T |
- |
- |
Unknown |
Substitution |
- |
GenBank |
LMNA_00251 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.374G>C |
- |
p.Gly125Ala |
Unknown |
Substitution |
- |
GenBank |
LMNA_00143 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.383_384ins24 |
- |
p.Ile128_Ala129insRVTLISSR |
Unknown |
Insertion |
- |
GenBank |
LMNA_00245 |
- |
A cohort of 64 patients with dilated cardiomyopathy was prospectively screened using both HRM and DHPLC methodologies. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.394G>C |
- |
p.Ala132Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00210 |
- |
novel mutation |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.398G>C |
- |
p.Arg133Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00020 |
- |
The G398C mutation creates/destroys recognition site for enzymes MspAI. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.398G>C |
- |
p.Arg133Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00020 |
- |
The first report to suggest that the A-type lamin mutations may be differentially dysfunctional for the same LMNA mutation. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.398G>T |
- |
p.Arg133Leu |
Unknown |
Substitution |
- |
GenBank |
LMNA_00034 |
- |
Atypical Werner |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.405_425dup |
- |
p.Lys135_Leu141dup |
Unknown |
Duplication |
- |
GenBank |
LMNA_00189 |
- |
a novel in-frame insertion,heterozygous mutation. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.406G>C |
- |
p.Asp136His |
Unknown |
Substitution |
- |
GenBank |
LMNA_00185 |
- |
APS patients have a few overlapping but some distinct clinical features as comparedrnwith HGPS and mandibuloacral dysplasia. The pathogenesis of clinical manifestations in APS pa-rntients seems not to be related to accumulation of mutant farnesylated prelamin A. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.419T>C |
- |
p.Leu140Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00075 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.419T>C |
- |
p.Leu140Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00075 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.427T>C |
- |
p.Ser143Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00134 |
- |
A novel mutation S143P in the lamin A/C gene was found to be common
among Finnish DCM patients. Haplotype analysis strongly suggests a founder effect of
this mutation. |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.427T>C |
- |
p.Ser143Pro |
Unknown |
Substitution |
- |
GenBank |
LMNA_00134 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.428C>T |
- |
p.Ser143Phe |
Unknown |
Substitution |
- |
GenBank |
LMNA_00092 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
./. |
02 |
c.433G>A |
- |
p.Glu145Lys |
Unknown |
Substitution |
- |
GenBank |
LMNA_00085 |
- |
The study of nuclear envelope functions is providing
remarkable new insights into fundamental aspects of
nuclear structure and dynamics.
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Legend |
How to query |
« First |
Prev |
|
1 |
2 |
3 |
4 |
5 |
|
Next |
Last » |